Infusion for Health

Infusion for Health

Private
Brea, CaliforniaHealthcare & Life Scienceshttps://www.infusionforhealth.com

Last Round

Debt

Mar 1, 2024

Total Funding Raised

$50M

Momentum Score

50 /100

Company Overview

Infusion for Health is a provider of specialty infusion therapies for patients with complex and chronic conditions, such as autoimmune and immunodeficiency disorders. Founded in 2015, the company operates a network of ambulatory infusion centers and also offers home infusion services, aiming to provide a patient-focused, comfortable, and cost-effective alternative to hospital-based treatments. The company started in Thousand Oaks, California, and began a national expansion in 2020. In 2021, Infusion for Health secured $50 million in funding to expand its geographic reach and services. The company is backed by private equity firms, including Oak HC/FT and Cimarron Healthcare Capital.

Sector

Healthcare & Life Sciences

Verticals

Patient Engagement, Revenue Cycle, Pharma Supply Chain

Business Model

B2B2C

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

infusion therapyinfusion centershome infusionambulatory infusion centersoutpatient infusionspecialty pharmacyinfusion clinicschronic disease managementinfusion suitesalternate site of careautoimmune disorder treatmentphysician referralspediatric infusionB2B2C healthcareprovider portal

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Infusion for Health Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Infusion for Health Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
DebtMar 1, 2024
Growth EquityNov 2, 2021
RecapSep 10, 2019

Key People

Founding team and executive leadership

Dan McCarty

Chief Executive Officer

Executive Team

Adam Holland

Chief Financial Officer

Executive Team

Craig Mercer

CFO At Infusion For Health

Executive Team

Infusion for Health Investors

Notable investors and investment history

InvestorRounds
Oak HC/FTGrowth Equity
Cimarron Healthcare CapitalGrowth Equity, Recap
Cimarron Capital PartnersGrowth Equity, Recap
K2 HealthVenturesDebt

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 1, 2026

    Manages up to 20 tenant improvement projects annually.

  • Dec 27, 2025

    Job posting suggests active evaluation and support for transactions.

Infusion for Health Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Infusion for Health Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Infusion for Health's valuation, stock price, and market status.

Firmographic Details

HeadquartersBrea, California
Employee Range160
Year Founded2015
Last FundingMar 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.